Private Advisor Group’s BeOne Medicines Ltd ONC Stock Holding History

Private Advisor Group’s Portfolio ONC Stock Details ONC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$310K	Buy	+1,088	New	+$321K	﹤0.01%	2091
2022 Q3	–	Sell	-3,407	Closed	-$551K	–	2154
2022 Q2	$551K	Buy	3,407 +2,251	+195%	+$352K	﹤0.01%	1362
2022 Q1	$218K	Sell	1,156 -244	-17%	-$51.9K	﹤0.01%	1852
2021 Q4	$379K	Sell	1,400 -488	-26%	-$165K	﹤0.01%	1605
2021 Q3	$685K	Buy	1,888 +984	+109%	+$322K	﹤0.01%	1358
2021 Q2	$310K	Buy	904 +107	+13%	+$35.4K	﹤0.01%	1617
2021 Q1	$277K	Buy	+797	New	+$264K	﹤0.01%	1578
2020 Q3	–	Sell	-31	Closed	-$6K	–	3504
2020 Q2	$6K	Buy	+31	New	+$5.05K	﹤0.01%	3190

Other funds holding ONC

BBA

Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

Temasek Holdings Singapore $37.3B AUM 12.6% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Private Advisor Group's ONC Position: Q2 2026 in Review

Private Advisor Group opened a new position in BeOne Medicines Ltd (ONC) in Q2 2026: 1,088 shares worth $310K. The stake represents ﹤0.01% of the portfolio and ranks #2091 among its holdings. This is a return to the name: Private Advisor Group previously reported a position in ONC as recently as Q2 2022.

Private Advisor Group first reported a position in ONC in Q2 2020 and has held it in 8 quarters since. The position peaked at $685K in Q3 2021. 282 funds tracked by Wall St. Rank hold ONC as of Q2 2026.

Private Advisor Group held 1,088 shares of BeOne Medicines Ltd worth $310K as of Q2 2026.
BeOne Medicines Ltd was a new Private Advisor Group position in Q2 2026.
BeOne Medicines Ltd made up ﹤0.01% of Private Advisor Group's portfolio in Q2 2026, its #2091 holding.
Private Advisor Group first reported a position in BeOne Medicines Ltd in Q2 2020 and has held it in 8 quarters since.
Private Advisor Group's BeOne Medicines Ltd position peaked at $685K in Q3 2021.
282 funds tracked by Wall St. Rank held BeOne Medicines Ltd as of Q2 2026.

Based on Private Advisor Group's 13F filing for Q2 2026, filed 27 Jul 2026.